The Partnership and Expansion Supervisor is a pivotal role within "Lemon" retail pharmacy team, responsible for developing and managing strategic partnerships, driving expansion initiatives, and ensuring the growth and success of "Lemon" retail pharmacy operations. This role requires a dynamic individual with strong leadership skills, business acumen, and a proven track record of fostering collaboration and driving results. I am playing a crucial role in advancing "Lemon" pharmacy's footprint… Show more The Partnership and Expansion Supervisor is a pivotal role within "Lemon" retail pharmacy team, responsible for developing and managing strategic partnerships, driving expansion initiatives, and ensuring the growth and success of "Lemon" retail pharmacy operations. This role requires a dynamic individual with strong leadership skills, business acumen, and a proven track record of fostering collaboration and driving results. I am playing a crucial role in advancing "Lemon" pharmacy's footprint and enhancing its reputation as a trusted healthcare provider in the community across the kingdom.Key Responsibilities:1- Partnership Development> Identify and establish strategic partnerships with healthcare providers, Hospitals, Polyclinics & Medical Centers to expand the reach and influence of "Lemon" pharmacy.> Collaborate with external stakeholders to negotiate mutually beneficial partnerships, focusing on customer referrals, co-marketing opportunities, and shared initiatives.2- Expansion Strategy:> Develop and execute expansion plans to open new retail pharmacy locations, considering market analysis, competitive landscape, regulatory requirements, and business feasibility.> Lead site selection, lease negotiations, and oversee the acquisition of new pharmacy locations.3- Team Leadership:> Foster a collaborative and motivating work environment that promotes teamwork, continuous improvement, and high performance. Show less

Working on some personal projects related to the medical field, and as a pharmaceutical sales consultant.

Carefully studied and evaluated the market in western area, identified the key stakeholders and key opinion leaders, discovered the needs and prepared a full proposal for launching the line products.> Neuropharmagen® (Pharmaco-Genetic Test), CardioCel® (CHD repairing tissue implant).> Targeting: Neuro-Psychiatrists  Pediatric: Cardiothoracic Surgeons.

Participated efficiently in the development and managed the implementation of the launch plan for the CNS line in the central region of Saudi Arabia with full responsibility of selecting, developing and managing the advisory board, thought leaders and local speakers and to develop/achieve hospitals and pharmacies introduction plan in addition to full responsibility for achieving the annual & monthly sales targets, I also participated in the expansion plan and in the selection of the team new… Show more Participated efficiently in the development and managed the implementation of the launch plan for the CNS line in the central region of Saudi Arabia with full responsibility of selecting, developing and managing the advisory board, thought leaders and local speakers and to develop/achieve hospitals and pharmacies introduction plan in addition to full responsibility for achieving the annual & monthly sales targets, I also participated in the expansion plan and in the selection of the team new candidates.STAR:Launched the anti-diabetic product Diamicron MR in MOH sector with full responsibility of generating department's requests for the SGH34 tender quantities and Direct Purchasing Orders (DPO's) along with maintaining a high demand for the mature anti-hypertensive product Natrilix SR resulted in the tremendous achievement of 130% quantities vs budget.> Central region: Private and Public sectors.> Launching: Central Nervous System (CNS) Line / VALDOXAN®.> Therapeutic Area: Depression, Diabetes, Cardiovascular.> Brands: (VALDOXAN®, Diamicron MR®, NATRILIX SR®)> Assisting in the implementation of VALDOXAN® marketing plan in the Central Region> Proposing an action plan every quarter to achieve VALDOXAN® planned market share and monitor its implementation among the team in coordenation with PM> Planning, coordinating and reporting VALDOXAN® regional team activities on monthly basis> Holding educational audiovisual events for HCP> Following up with the team on VALDOXAN® regional marketing projects> Conducting market share analysis and market intelligence to identify market gaps and potential opportunities> Testing the promotional cycle message and reporting customer’s feedback to the product manager> 500’000 SR turnover & 101% achievement versus annual Targets for CNS line> 5.5 Million SR turnover & 130% achievement versus SGH34 tender targets for MOH line> Targeting: @ Neuro-Psychiatrists @ Endocrinologists @ Cardiologists @ Internists @ Primary Care Show less

Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line, handling their objections, influencing their practice, and generating high volume of prescriptions in the right patient segment to create demand and achieve leadership in sales & market share.• Central region: Private sector.• Launching: Osteoporosis Line / Protelos®: “Award of successful launch."• Therapeutic Area:… Show more Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line, handling their objections, influencing their practice, and generating high volume of prescriptions in the right patient segment to create demand and achieve leadership in sales & market share.• Central region: Private sector.• Launching: Osteoporosis Line / Protelos®: “Award of successful launch."• Therapeutic Area: Osteoporosis, Diabetes, Cardiovascular, Depression, Venous insufficiency, Hemorrhoids.• Brands: (Protelos®, DiamicronMR®, BiPreterax® Coversyl®, VastarelMR®, Stablon®, Daflon®)• Targeting:  Orthopedics Endocrinologists Cardiologists  Internists  Primary Care Psychiatrists. Show less

Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line to achieve leadership in sales & market share, I was responsible for reporting any event of unexpected/undocumented side effect of any kind to the pharmacovigilance department.Central region: Private / Public sectors [1 year]. (2004-2005)Launching: (NSAID-Brand) Roxonin®, (Clarithromycin-Generic) Clarex® in the central area (private… Show more Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line to achieve leadership in sales & market share, I was responsible for reporting any event of unexpected/undocumented side effect of any kind to the pharmacovigilance department.Central region: Private / Public sectors [1 year]. (2004-2005)Launching: (NSAID-Brand) Roxonin®, (Clarithromycin-Generic) Clarex® in the central area (private sector).Therapeutic Area: (BPHP) Benign Prostatic Hyperplasia, Pain & Joint Inflammatory Diseases, Infections, (GIRD) Gastroesophageal Reflux Disease. Brands: (Omnic®, Roxonin®)Generics: (Clarex®, Floxacin®, Josaxin®, Omyprex®).Targeting:  Urologists  Orthopedics  Dentists  Internists  Primary Care. Show less

Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line to achieve leadership in sales & market share, I was responsible for reporting any event of unexpected/undocumented side effect of any kind to the pharmacovigilance department.Lilly / Western region: Private sector [1 year]. (2003-2004)Launching: Erectile Dysfunction line / Cialis®.Therapeutic Area: (ED) Erectile Dysfunction… Show more Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line to achieve leadership in sales & market share, I was responsible for reporting any event of unexpected/undocumented side effect of any kind to the pharmacovigilance department.Lilly / Western region: Private sector [1 year]. (2003-2004)Launching: Erectile Dysfunction line / Cialis®.Therapeutic Area: (ED) Erectile Dysfunction, Osteoporosis, Depression.Brands: (Cialis®, Evista®, Prozac®)Targeting:  Urologists  Orthopedics  Psychiatrists  Internists  Primary Care. Show less